The protective effects of puerarin in cardiomyocytes from anoxia/reoxygenation injury are mediated by PKCε

Cell Biochemistry and Function

Volumn 32, Issue 4, 2014, Pages 378-386

  Tang, Lei ^a   Liu, Dan ^a   Yi, Xiaoqing ^a   Xu, Tiantian ^a   Liu, Ying ^a   Luo, Yuchao ^a   Yin, Dong ^a   He, Ming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Anoxia reoxygenation; Cardioprotection; PKC epsilon; Puerarin

Indexed keywords

PROTEIN KINASE C EPSILON; PROTEIN KINASE C EPSILON INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; PUERARIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CARRIER PROTEIN; ISOFLAVONE DERIVATIVE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOXIA; APOPTOSIS; ARTICLE; ASSAY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; NEWBORN; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; ISOFLAVONES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; PROTEIN KINASE C-EPSILON; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84901793399     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3026     Document Type: Article

References (34)

1. Minamino T. Cardioprotection from ischemia/reperfusion injury. Circ J 2012; 76: 1074-1082. doi:10.1253/circj.CJ-12-0132.
2. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609. doi:10.1152/physrev.00024.2007.
3. Shi WG, Qu L, Wang JW. Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 21-24.
4. Luo ZK, Liu Y, Li HM. A clinical efficacy and safety study on coronary heart disease and angina treatment with puerarin injection. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 614-616.
5. Wang Q, Wu T, Chen X, et al. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006: CD004196. DOI: 10.1002/14651858.CD004196.pub2
6. Wu XP, Feng JG, Chen HM, et al. Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26: 255-257.
7. Zhang NB, Huang ZG, Cui WD, Ding BP. Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat. J Ethnopharmacol 2011; 138: 737-740. DOI: 10.1016/j.jep.2011.10.013 S0378-8741(11)00751-3 [pii]
8. Fan LL, Sun LH, Li J, et al. Protective effect of puerarin against myocardial reperfusion injury. Myocardial metabolism and ultrastructure. Chin Med J 1992; 105: 451-456.
9. Yuan SM, Jing H. Insights into the monomers and single drugs of Chinese herbal medicine on myocardial preservation. Afr J Tradit Complement Altern Med 2011; 8: 104-127.
10. Miura T, Tanno M, Sato T. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 2010; 88: 7-15. doi:10.1093/cvr/cvq206.
11. Watkins SJ, Borthwick GM, Arthur HM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cellular & Developmental Biology - Animal 2010; 47: 125-131. doi:10.1007/s11626-010-9368-1.
12. Baines CP, Song CX, Zheng YT, et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003; 92: 873-880. DOI: 10.1161/01.RES.0000069215.36389.8D01.RES.0000069215.36389.8D [pii]
13. Chung MJ, Sung NJ, Park CS, et al. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. Eur J Pharmacol 2008; 578: 159-170. DOI: S0014-2999(07)01094-1 [pii] 10.1016/j.ejphar.2007.09.036
14. Yu Z, Li W. Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett 2006; 238: 53-60. DOI: S0304-3835(05)00588-4 [pii] 10.1016/j.canlet.2005.06.022
15. Hu W, Yang X, Zhe C, Zhang Q, Sun L, Cao K. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-kappaB activation in LPS-induced RAW264.7 macrophage cells. Pharmacol Rep 2011; 63: 781-789.
16. Zhang SY, Chen G, Wei PF, et al. The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction. J Asian Nat Prod Res 2008; 10: 373-381.
17. Zhang S, Chen S, Shen Y, et al. Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol Pharm Bull 2006; 29: 945-950.
18. Wu P, Zeng F, Ma HX. Study on effect of Puerarin on nitric oxide system in rats' tissue and its mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001; 21: 196-198.
19. Xie RQ, Du J, Hao YM. Myocardial protection and mechanism of puerarin injection on patients of coronary heart disease with ischemia/reperfusion. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23: 895-897.
20. He H, Shi M, Yang J, et al. The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin. Phytother Res 2008; 22: 948-956.
21. Chen R, Xue J, Xie M. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-beta1 expression. J Nutr Biochem 2012; 23: 1080-1085.
22. Pan ZY, Bao ZS, Wu ZM, et al. The myocardial protective effects of puerarin on STZ-induced diabetic rats. Fen Zi Xi Bao Sheng Wu Xue Bao 2009; 42: 137-144.
23. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 2008; 295: H874-882. DOI: 10.1152/ajpheart.01189.2007 01189.2007 [pii]
24. Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, Garlid KD. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem 2006; 281: 20801-20808. DOI: M600959200 [pii] 10.1074/jbc.M600959200
25. O'Rourke B Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 2004; 94: 420-432. DOI: 10.1161/01.RES.0000117583.66950.43 94/4/420 [pii]
26. Yao H, Gao Q, Xia Q. The role of mitochondrial K+ channels in the cardioprotection of puerarin against hypoxia/reoxygenation injury in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2010; 26: 459-462.
27. Yang B, Gao Q, Yao H, Xia Q. Mitochondrial mechanism of cardioprotective effect of puerarin against H202-stress in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2008; 24: 399-404.
28. Gao Q, Pan HY, Bruce IC, Xia Q. Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion. Conf Proc IEEE Eng Med Biol Soc 2005; 6: 5591-5594. doi:10.1109/IEMBS.2005.1615753.
29. Dong K, Tao QM, Shan QX, et al. Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta. Conf Proc IEEE Eng Med Biol Soc 2004; 5: 3757-3760. doi:10.1109/IEMBS.2004.1404054.
30. Pan HY, Gao Q, Yao H, Xia Q. The protective role and the mechanisms of puerarin on isolated rat heart during ischemia/reperfusion. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2006; 22: 455-459.
31. Gao Q, Pan HY, Qiu S, et al. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart. Life Sci 2006; 79: 217-224. DOI: S0024-3205(06)00014-2 [pii] 10.1016/j.lfs.2005.12.040
32. Liu CM, Ma JQ, Sun YZ. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. Exp Toxicol Pathol 2012; 64: 575-582. DOI: 10.1016/j.etp.2010.11.016 S0940-2993(10)00207-1 [pii]
33. Li R, Xu L, Liang T, Li Y, Zhang S, Duan X. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. Food Chem Toxicol 2013; 52: 69-75. DOI: 10.1016/j.fct.2012.10.059 S0278-6915(12)00804-6 [pii]
34. Xiao C, Li J, Dong X, et al. Anti-oxidative and TNF-alpha suppressive activities of puerarin derivative (4AC) in RAW264.7 cells and collagen-induced arthritic rats. Eur J Pharmacol 2011; 666: 242-250. DOI: 10.1016/j.ejphar.2011.05.061 S0014-2999(11)00644-3 [pii]